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Snake venom metalloproteinases (SVMP) are abundant toxins in venoms of viper snakes
and play a relevant role in the complex and multifactorial tissue damage characteristic of
Viperidae envenoming. Jararhagin, a SVMP isolated from Bothrops jararaca venom, induces
a fast onset hemorrhagic lesions acting directly on the capillary vessels, which are dis-
rupted by toxin adhesion and degradation of extracellular matrix proteins like collagen IV.
Jararhagin also triggers inﬂammatory response, where endothelial cells are activated,
resulting in the enhanced rolling of circulating leukocytes, nitric oxide generation, pros-
tacyclin production and pro-inﬂammatory cytokines release. Jararhagin also decreases
endothelial cells viability inducing apoptosis (in vitro studies). In the present study we
attempted to correlate the effect of sub-apoptotic doses of jararhagin on human umbilical
vein endothelial cells (HUVECs) and gene expression of pro-inﬂammatory mediators, using
microarray assay, real time PCR and detection of speciﬁc proteins on HUVEC surface or
released in the medium. Jararhagin was effective in activate and up-regulate the gene
expression of different mediators such as E-selectin, VCAM-1, IL-8, CD69, Ang-2 and MMP-
10. Despite the increase in expression of genes coding for such molecules, jararhagin did
not induce increased concentrations of E-selectin, VCAM-1 and IL-8 produced or released
by endothelial cells. In conclusion, jararhagin is able to activate pro-inﬂammatory gene
transcription on endothelial cells however this stimulus is not sufﬁcient to result in the
consequent expression of pro-inﬂammatory effectors molecules like E-selectin, VCAM-1
and IL-8. The time courses of these events, as well as the doses of jararhagin are impor-
tant points to be addressed herein.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
The Brazilian Ministry of Health registered 25,189 cases
of accidents with venomous snakes in 2010 and enveno-
mations caused by Bothrops snakes were the most frequent
(72.5%). One of the most striking local effects observed
during the poisoning is pain, swelling, degradation of087; fax: þ55 11 3726
lissa).
lsevier OA license.connective tissue, blood vessels, muscle cells, among other
physiological components. In some cases tissue injury can
result in permanent disability of the affected member. The
only treatment currently available for bothropic accidents
is the serumtherapy with speciﬁc antivenom. However this
procedure is not effective for neutralization of local tissue
damage since the action of venom toxins is very fast and
include activation of different endogenous targets affecting
the homeostasis of the organism (Gutierrez et al., 1998). In
this regard, any delay between the bite and the beginning
of serumtherapy is crucial for a critical prognosis of these
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highly dependent upon the characterization of the endog-
enous mediators and mechanisms involved in the onset of
local tissue damage and these approaches improve the
knowledge about the pathology and consequently the
development of new strategies to relieve these serious
effects.
Technological advances inmicroarray applications allow
for a rapid analysis of the functional effects of different
substances on gene expression proﬁles of biological
systems. Several studies in the literature bring new
knowledge about the functional genomics of snake venoms
action on different cells and tissues. Early studies per-
formed by Gallagher et al. (2003) compared the gene
expression proﬁles of human endothelial cells submitted to
subtoxic concentrations of Crotalus atrox and Bothrops jar-
araca venoms demonstrating the power of gene expression
proﬁling to explore effects of venoms and for the discovery
of biological processes and signal transduction pathways
involved in the pathology (Gallagher et al., 2003).
One of the most abundant proteins found in the B. jar-
araca venom, snake venom metalloproteinases, are zinc-
dependent proteinases, which belongs to the Reprolysin
subfamily. Analysis of gene expression of the venom gland
from B. jararaca snake showed that more than 50% of
transcribed genes belong to SVMPs (Cidade et al., 2006).
These are multidomain Zn2þ-dependent enzymes that
share structural and functional motifs with other metal-
loproteinase, like the MMPS (matrix metalloproteinases)
and ADAMs (a disintegrin and metalloproteinase) (Bode
et al., 1993; Stocker et al., 1995). SVMPs are classiﬁed in
classes from PI to PIII according to the presence or absence
of disintegrin and cysteine-rich domains together with
a typical metalloproteinase domain at least in the precursor
molecule form (Fox and Serrano, 2008).
SVMPs play a relevant role in the complex local
pathology induced during this envenoming and are directly
involved in the hemorrhage and inﬂammatory responses
characteristic of bothropic envenomations.
Inﬂammatory events promoted by jararhagin follows
a typical acute inﬂammation proﬁle, with accumulation of
leukocytes in murine subcutaneous tissue, predominantly
neutrophils and pain and edema when injected into the
footpad of rats (Costa et al., 2002 Dale et al., 2004). The role
of pro-inﬂammatory cytokines in the development of local
tissue damage induced by jararhagin was studied in mice
deﬁcient in pro-inﬂammatory cytokines and their key
receptors, where it was shown that jararhagin-induced
necrosis was totally abolished in knockout mice deﬁcient
in TNF-a receptors (TNFR1 and TNFR2) and was partially
reduced in knockout mice deﬁcient in cytokine IL-6.
However, the edema and hemorrhage occurred indepen-
dently of the inﬂammatory mediators investigated, sup-
porting the view that these lesions are induced by the
direct activity of venom metalloproteinases on different
cells and tissues (Laing et al., 2003).
Concerning the effect of SVMPs in different cell types,
jararhagin induces the production of pro-inﬂammatory
cytokines by murine macrophages, increasing the mRNA
translation for IL-6, TNF-a and IL-1b (Clissa et al., 2001). In
human ﬁbroblasts, a variety of genes associated with pro-inﬂammatory response was observed to be up-regulated by
jararhagin as IL-8, IL-11, CXCL2, IL-1b, IL-6, MMP-10,MMP-1;
changes in gene expression induced by jararhagin were also
observed in mouse gastrocnemius muscle tissue where the
up-regulation of IL-1b, IL-6, CXCL1, CXCL2, IL-8 and TNF-
a induced protein 6 was observed (Gallagher et al., 2005).
Our current study was focused on endothelial cells, since
they are key regulators of the inﬂammatory response. In the
case of injury, endothelial cells lining blood vessels control
the adhesion and migration of inﬂammatory cells, as well as
the exchangeofﬂuid fromthebloodstream into thedamaged
tissue (Kadl and Leitinger, 2005). In this aspect, when topi-
cally applied to mouse cremaster muscle, jararhagin
increased signiﬁcantly the number of leukocytes rolling on
the vessel wall of post-capillary venules demonstrating
a pronounced effect on the leukocyte–endothelial interac-
tion. This increased number of cells was maintained during
the following 20 min of observation (Clissa et al., 2006).
The effects of jararhagin on endothelial cells in culture
medium are highlighted by induction of apoptosis with
activation of pro-caspase-3 and alterations in the ratio
between Bax/Bcl-xL. The apoptosis was followed by
decrease of cell viability and loss of cell adhesion to the
substrate, accompanied by a rearrangement of actin
network and a decrease in FAK association to actin and in
tyrosine phosphorylated proteins characterizing an anoikis
effect (Baldo et al., 2008; Tanjoni et al., 2005).
In the present study we investigated the effect of jar-
arhagin on human vascular endothelial cells (HUVEC),
analyzing the gene expression with particular attention to
pro-inﬂammatory related transcripts. Our results show the
action of this PIII SVMPmodulating the expression of genes
involved in different biological effects, such as cell death,
signaling, cell–cell interaction, cellular movement, among
others but predominantly genes related to inﬂammatory
responses. The up-regulated pro-inﬂammatory transcripts
were further validated by qPCR and analyzed by protein
expression at cell surface or culture supernatants.
2. Material and methods
2.1. Jararhagin puriﬁcation and depyrogenation
Jararhagin was puriﬁed from B. jararaca venom by
hydrophobic interaction and anion exchange chromatog-
raphy as previously described by Paine et al. (1992). To
remove remaining lipopolysaccharide (LPS) contamina-
tions frompuriﬁed jararhagin, this toxinwas submitted to 1
cycle of treatment by Triton X-114 as previously described
(Aida and Pabst, 1990). The presence of LPS in treated
samples was evaluated by Limuls Amebocyte Lysate test
(LAL-Charlys River). The hemorrhagic activity of Triton-
treated jararhagin was measures in the mouse skin
(Kondo et al., 1960) and cell viability assaywas evaluated by
MTT method (Tanjoni et al., 2005). Jararhagin LPS-free was
used for all cell culture experiments.
2.2. Jararhagin treatment of endothelial cells
Human vascular endothelial cells (HUVECS) obtained
from umbilical cords of newborns (Hospital of University of
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were aseptically harvested in our laboratory as described
before (Jaffe et al., 1973) and cultured on 0.1% gelatin-
coated plastic bottles (75 cm2) in the presence of RPMI
1640 medium supplemented with 10% Fetal Bovine Serum
(FBS), 2 mM L-glutamine, 1 mM sodium pyruvate, 100 UI/
mL penicillin, 100 mg/mL streptomycin, 50 mM 2-
mercaptoethanol, 5 U/mL heparin, 20 ng/mL bFGF, and
10 ng/mL EGF. The cells were used until the 5th passage.
The cells were grown in 25 cm2 plastic bottles until reach
a conﬂuent monolayer and then they were treated with
different doses of jararhagin diluted in the supernatant,
during 1, 3, 6, 24 or 48 h, according to the experiment. Cells
treated with PBS diluted in the supernatant were used as
control group.
2.3. Cell viability and cell detachment of HUVECs
Cell viability and cell detachment induced by jararhagin
was evaluated using the MTT assay (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide).
Cells were seeded at the concentration of 5  104 cells per
well in 96 well microplates, previously coated with gelatin
1%. After 24 h, themediumwas changed and supplemented
with the same complements cited above, except the growth
factors. The samples containing jararhagin (100, 200, 400
or 600 nM) and negative controls (PBS 1:10 in culture
media or LPS 1 mg/mL) were added in the time zero and
kept during the time course of the experiment (48 h) in
37 Cwith 5% CO2. The total cell lyses was induced by sterile
distilled water.
For the experiment of cell viability, after 24 and 48 h,
20 mL/well of MTT (5 mg/mL diluted in PBS) was added to
the culture medium and kept for 3 h at 37 C. The formazan
crystals resulting from MTT reduction were dissolved by
addition of 100 mL of PBS containing 10% SDS and 0.01 NHCl
(18 h, 37 C and 5% CO2) and the infrared light absorption
was read using an plate spectrophotometer (Multiskan EX –
Thermo) at 490 nm.
To quantify the cell detachment induced by jararhagin,
the same procedure for cell culturewas used, however after
24 or 48 h the detached cells were removed by two careful
washes using PBS and the remaining cells were stained by
MTT assay as described above. For both experiments, the
absorbance was read on a multiwell scanning spectropho-
tometer (ELISA reader) using a ﬁlter of 570 nm.
2.4. Gene expression
For the microarray experiment, cultures of HUVECs
were incubated with 200 nM of jararhagin or PBS (control
group) for 24 h and total RNA was harvested using Trizol
reagent (Invitrogen). Double-stranded cDNA and labeled
cRNA were synthesized as described before (Gallagher
et al., 2003). Total RNA integrity was assessed by analysis
with an Agilent Bioanalyzer using RNA 6000 Nano chips.
Ten microgram samples of biotin-labeled cRNA were
hybridized to Affymetrix HgU133 A probe arrays for 16 h,
and scanned with the Affymetrix Gene-Array Scanner.
For the real-time PCR experiments, cultures of HUVECs
were incubated with 200 nM of jararhagin, PBS (negativecontrol group) or 1 mg/mL of LPS (positive control group) for
3, 6 and 24 h. The RNA (5 mg) was extracted in Trizol
solution (Invitrogen) according to the manufacturer’s
instructions and reverse transcribed using 200 U/mL of
Superscript III RT (Invitrogen) at 50 C for 60 min in the
presence of 50 mM Oligo(dT), 10 mM dNTP Mix, 5 First-
Strand buffer, 100 mM DTT, Rnase OUT inhibitor (40 U/mL).
The reaction was inactivated by warming to 70 C for
15 min. Quantitative RT-PCR was performed using Line
Gene K Thermal Cycler (Hangzhou Bioer Technology Co.)
using the fqdpcr-4.2.20 software and 25 mL Master Mix –
Sybr Green Rox Plus (LGC Biotechnology), 200 ng cDNA and
170 nM of each primer. The following thermal cycling
protocol was used: 15 min at 95 C followed by 40 cycles of
15 s at 95 C, 30 s at 60 C, and 30 s at 72 C. The primers
sequences were designed using sequence alignments ob-
tained at NIH/NCBI gene bank based in the RNA published
sequence.
The data were normalized using b-actin as a house-
keeping gene and then analyzed by comparative threshold
cycle (CT) method to calculate fold changes of expression in
jararhagin treated groups compared with PBS treated
groups, where: DCT ¼ CT of gene of interest minus CT of b-
actin and DDCT ¼ DCT of jararhagin treated groups minus
DCT of PBS treated groups. Fold changes in gene expression
for jararhagin treated groups were then calculated as 2DDCT .
All real time experiments were performed in triplicate of
two independent cell culture experiments.
2.5. Protein detection
The expression of E-selectin, VCAM-1 and PECAM-1 on
the membrane surface of HUVECs incubated with PBS,
jararhagin (200 nM) or LPS (1 ng/mL) was analyzed at 1, 3, 6
and 24 h by ﬂow cytometry. The cells previously stimulated
with these agents were gently detached from the cell
culture plates using a cell lifter. A total number of 0.5  106
cells were incubated in suspension with anti-human FcgR-
Binding Inhibitor at the concentration of 1 mg/106 cells (BD
System) for 20 min/4 C followed by washing with PBS
containing 1% serum albumin (BSA) and centrifugation
(300 g/10 min). The expression of different molecules was
analyzed by the cell incubation with anti-human CD31/
PECAM-1-ﬂuorescein, anti-human E-selectin-ﬂuorescein,
anti-human VCAM-1-ﬂuorescein monoclonal antibodies at
a concentration of 1 mg/106 cells (R&D Systems) in PBS with
1% BSA for 30 min/4 C. All the cell suspensions were also
incubated with the respective ﬂuorescein-labeled isotype
control monoclonal antibodies (e-Bioscience). The cells
were washed and resuspended in PBS containing 0.1%
paraformaldehyde. The cells cytometric analyses (104
events per data acquisition ﬁle) were performed with
FACScalibur using Cell Quest software (Becton Dickinson).
All ﬂow cytometry experiments were performed in tripli-
cate of three independent experiments.
Soluble E-selectin and IL-8 released in the HUVECs
culture supernatants were measured in the ﬁrst 6 h of
treatment with jararhagin (200 nM) or LPS (1 ng/mL) by
ELISA, according to the manufacturer’s instructions (Duo
Set ELISA Development Systems – R&D Systems). The
concentrations of E-selectin and IL-8 were calculated by
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recombinant proteins as provided in the Duo Set System
and the results were reported as pg/mL of cell culture
supernatant.2.6. Statistical analysis
The data were presented as mean  standard deviation
(SD) for each group. Differences between groups were
assessed by Student-t test; Two-way ANOVA and the Bon-
ferroni multiple comparison test using the GraphPad Prism
Software v 4.0 (Inc., San Diego, USA). A p value < 0.05 was
considered as statistically signiﬁcant for themicroarray and
real-time experiments. The cell viability and cell detach-
ment experiments were analyzed with p value < 0.01.
3. Results
3.1. Cell detachment and viability of jararhagin-treated
HUVECs
This experiment was performed in order to establish the
minimal dose of jararhagin that would induce cell adhe-
sion, small decrease in cell viability andwith the capacity to
activate human vascular endothelial cells. We can observe
in Fig. 1 that HUVECs treated with different doses of jar-
arhagin did not detach from the substrate (gelatin 0.1%)Fig. 1. Effects of jararhagin on HUVEC cell detachment from the substrate
(gelatin 1%) and cell adhesion viability. Primary cultures of HUVEC were
treated with 100, 200 or 400 nM of jararhagin or LPS (1 mg/mL) over a period
of 48 h. In different times intervals, cell detachment and viability were
evaluated as described in Experimental procedures. The experiment was
performed in triplicate and the data are expressed as mean  sd of one
representative experiment. Signiﬁcance was calculated by Student’s T test
and the symbol * correspond to p < 0.001, when jararhagin data were
compared to PBS at the same experimental condition.during the ﬁrst 6 h (Fig. 1A). However after 24 and 48 h,
a signiﬁcant cell detachment was observed for all doses of
jararhagin (Fig. 1A). Moreover, a decrease of cell viability
was observed after 24 h of jararhagin treatment increasing
according to the dose (100, 200 or 400 nM) and this effect
was more accentuated after 48 h (Fig. 1B). Thus we can
conclude that the effects of jararhagin on cell detachment
and viability are dose and time-dependent. Considering
previous study performed by our group, showing that
800 nM of jararhagin on HUVECs induces 50% of cell
detachment from the substrate and 12% of cells undergo
apoptosis during the ﬁrst 24 h (Baldo et al., 2008), we used
200 nM of jararhagin in our experiments as a low toxic and
sub-apoptotic dose, inducing a partial endothelial cell
detachment during the ﬁrst 24 h of treatment. The LPS
(1 mg/mL) was used as a positive control of endothelial cell
activation and did not induce any cell detachment from the
substrate or cell toxicity, at all time intervals analyzed.
3.2. Gene expression proﬁle of jararhagin-treated and un-
treated HUVECs
To gain a global perspective from the nature of the
changes in HUVECs gene expression induced by jararhagin
treatment (200 nM at 24 h) a microarray experiment was
performed using the Affymetrix HgU133 A probe set. The
GeneChip data obtained were analyzed using Ingenuity
Pathway Analysis Software. This analysis identiﬁed that
jararhagin modulated the expression of genes involved in
a number of different biological effects, such as signaling
and cell–cell interaction, cell death, immune or inﬂamma-
tory response, cellular movement and hematological
system development and function. The software identiﬁed
in the jararhagin-treated HUVECs 59 up-regulated genes
with fold changes greater than 1.5 and p values < 0.05 and
11 down-regulated genes with fold changes greater than
1.5 and p values < 0.05 compared to un-treated cells.
Analyzing the results according to the inﬂammatory
response induced by jararhagin on HUVECs, among these
59 up-regulated genes, 25 were related directly or indi-
rectly with the inﬂammatory response. Down-regulated
genes with fold changes greater than 1.5 were detected
in 7 genes corresponding to inﬂammatory mediators (the
complete abbreviations and acronyms of each gene is
shown in Table 1). Jararhagin up-regulated the expression
of 14 important genes involved in cell signaling and cell–
cell interaction: E-selectin, VCAM-1, IL-8, IL-6, THBD, SULF1,
CXCL-6, ANGPT2, CDKN1B, DTR, DAF, TLN1, CSF2RBIL,
IL1RL1 (respective fold changes were 5.33; 2.75; 2.23; 1.97;
1.97; 1.95; 1.91; 1.88; 1.82; 1.75; 1.66; 1.64; 1.59; 1.54).
Another gene group up-regulated by jararhagin is related to
cell death, with expression of 20 genes: CD69, SAT, VCAM-1,
IL-8, CEPBD, IL-6, THBD, SULF1, ANGPT2, CDKN1B, SOD2,
DTR, PEG10, ARG2, GULP1, DAF, CSF2RB, ILRL1, BTG1,
SH3BP5 (respective fold changes were 3.39; 3.23; 2.75;
2.23; 2.15; 1.97; 1.97; 1.95; 1.88; 1.82; 1.78; 1.75; 1.74; 1.69;
1.67; 1.66; 1.59; 1.54; 1.54; 1.53). A total of 10 genes
involved with inﬂammatory diseases were up-regulated by
jararhagin: E-selectin, SAT, IL-8, CEBPD, IL-6, SOD2, MMP-
10, ARG2, DAF, IL1RL1 (5.33; 3.23; 2.23; 2.15; 1.97; 1.78;
1.73; 1.69; 1.66; 1.54).
Table 1
Fold changes of up and down-regulated genes expressed in HUVECs treated with jararhagin for 24 h analyzed by a microarray experiment performed on
Affymetrix HgU133 A probe and analyzed by Ingenuity software.
Gene
abbreviation
Fold
change
Cell to cell
signaling and
interaction
Cell
death
Inﬂammatory
disease
Cellular
movement
Hematological system
development and
function
Gene name
SELE 5.33 ** ** ** ** Selectin E (endothelial adhesion molecule 1)
CD69 3.39 ** ** ** CD69 antigen (p60. early T-cell activation antigen)
SAT 3.23 ** ** Spermidine/spermine N1-acetyltransferase
VCAM-1 2.75 ** ** ** ** Vascular cell adhesion molecule 1
IL-8 2.23 ** ** ** ** ** Interleukin 8
CEBPD 2.15 ** ** CCAAT/enhancer binding protein (C/EBP). delta
IL-6 1.97 ** ** ** ** ** Interleukin 6 (interferon. beta 2)
THBD 1.97 ** ** ** Thrombomodulin
SULF1 1.95 ** ** ** Sulfatase 1
CXCL-6 1.91 ** ** ** Chemokine (C-X-C motif) ligand 6
ANGPT2 1.88 ** ** ** ** Angiopoietin 2
CDKN1B 1.82 ** ** ** ** Cyclin-dependent kinase inhibitor 1B (p27. Kip1)
SOD2 1.78 ** ** Superoxide dismutase 2. mitochondrial
DTR 1.75 ** ** ** ** Diphtheria toxin receptor
PEG10 1.74 ** Paternally expressed 10
MMP-10 1.73 ** Matrix metalloproteinase 10 (stromelysin 2)
ARG2 1.69 ** ** Arginase. type II
GULP1 1.67 ** GULP. engulfment adaptor PTB domain
containing 1
DAF 1.66 ** ** ** ** ** Decay accelerating factor for complement (CD55)
TLN1 1.64 ** Talin 1
CSF2RB 1.59 ** ** ** Colony stimulating factor 2 receptor. beta.
low-afﬁnity
PLCB1 1.55 ** Phospholipase C. beta 1 (phosphoinositide-speciﬁc)
IL1RL1 1.54 ** ** ** ** ** Interleukin 1 receptor-like 1
BTG1 1.54 ** B-cell translocation gene 1. anti-proliferative
SH3BP5 1.53 ** SH3-domain binding protein 5 (BTK-associated)
ANGPTL4 1.51 ** Angiopoietin-like 4
HES1 1.54 ** ** Hairy and enhancer of split 1. (Drosophila)
JAG2 1.56 ** ** Jagged 2
BGN 1.61 ** Biglycan
DDIT4 1.63 ** DNA-damage-inducible transcript 4
JAG1 2.2 ** ** ** Jagged 1 (Alagille syndrome)
BHLHB2 2.3 ** Basic helix-loop-helix domain containing.
class B. 2
**Means involved.
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expression and quantitation of 8 genes from those up-
regulated in microarray analysis. We chose representative
genes in each one of the biological effects cited above: E-
selectin, VCAM-1, IL-8, IL-6, CXCL-6, ANGPT2; CD69, VCAM-
1 and MMP-10. The RNA was extracted from HUVECs at 3
different time-points (3, 6 and 24 h) after the treatment
with jararhagin (200 nM). The cDNA was transcribed and
quantiﬁed by real time PCR using the relative quantiﬁcation
method (2DDCT ). We performed the treatment of HUVECs
with LPS 1 mg/mL as a positive control in our experiments,
indicating that the cells were responsive and our sample
was completely depyrogenated. LPS was used as positive
control for our experiments once we selected genes for
inﬂammatory response and it stimulates leukocyte and
blood endothelium through the LPS recognition systems,
binding with CD14 and transferring to TLR4 and MD-2
complex, resulting in the production of downstream
inﬂammatory cytokines and leukocyte adhesion molecules
by the activation of NF-kB and AP-1-dependent transcrip-
tional pathways (Sawa et al., 2008).
Our results shown in Fig. 2 and Table 2 demonstrate that
LPS as expected was extremely potent to induce a very
signiﬁcant gene expression of E-selectin, VCAM-1, IL-6, IL-8,CXCL-6 and CD69 at all times analyzed, while a signiﬁcant
increase ingeneexpression forMMP-10wasdetectedonlyat
6 and 24 h. The gene expression of ANG-2 LPS-induced was
not detected at any time point. Considering the jararhagin
treatedHUVECswecan observe that no gene expressionwas
detected at the time point of 3 h, while signiﬁcant increase
was observed at 6 h for the genes coding for E-selectin,
VCAM-1, IL-8, CD69, ANG-2 and MMP-10. After 24 h, jar-
arhagin induced a signiﬁcant up-regulation of gene
expression of E-selectin, VCAM-1, CD69 and ANG-2.
Comparing the relative concentration of mRNA for those
genes, obtained between LPS and jararhagin treatment
(Table 2) we can observe very high levels of some genes
expressed by LPS. This result suggest that the signaling
pathways activated by these two samples are completely
different and jararhaginwouldnot activate toll like receptors
as LPS, but other receptors as integrins present on HUVEC
cell surface, which may induce lower activation signals.
3.3. Protein expression of E-selectin, VCAM-1, PECAM-1 and
IL-8
In order to identify a positive correlation between
mRNA translation and protein production induced by
Fig. 2. Relative quantiﬁcation of mRNA expression of genes coding for E-selectin, VCAM-1, IL-8, CXCL-6, CD69, IL-6, MMP-10, Angiopoetin-2 in HUVECs stim-
ulated with jararhagin. HUVECs were treated with jararhagin (200 nM), LPS (1 mg/mL), or PBS (control group) for 3, 6 and 24 h. The total RNA was extracted and
transcribed to cDNA and the gene expression was quantiﬁed by real time PCR. Columns show the relative concentration of each cDNA compared with the PBS
group and the housekeeping gene b-actin. Signiﬁcance was calculated by two-way ANOVA, and the different treatments were performed independently in the
statistical analysis. Results are shown as mean  sd of three independent experiments. The symbol * represents p < 0.05 relative to PBS group.
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and VCAM-1was investigated on endothelial cell surface by
ﬂow cytometry. As shown in Fig. 3, PECAM-1 expression on
HUVECs incubated with PBS, jararhagin or LPS for 1, 2 or 6 hwas very similar between the groups, conﬁrming the
constitutive molecule expression. Interestingly PECAM-1
expression was signiﬁcantly lower on HUVECs treated for
24 h with jararhagin, indicating that the expression of this
Table 2
Relative quantiﬁcation of gene expression induced by treatment of
HUVECs with jararhagin (200 nM) or LPS (1 mg/mL) during 3, 6 or 24 h.
Genes Jararhagin-induced
expression (fold change)
LPS-induced
expression (fold change)
3 h 6 h 24 h 3 h 6 h 24 h
SELE – 49 7 150 700 300
VCAM-1 – 4 3 140 360 46
IL-6 – – – 20 – 29
IL-8 – 9 – 120 175 215
CXCL-6 – – – 50 120 155
CD69 – 11 10 58 60 78
ANG-2 – 5 6 – – –
MMP-10 – 4 – – 2 7
D.S. Lopes et al. / Toxicon 60 (2012) 1072–10841078molecule is decreasing probably due the apoptosis process.
The adhesion molecule E-selectin (Fig. 4) was signiﬁcantly
up-regulated in HUVECs stimulated with LPS at 3 and 6 h,
while jararhagin did not induce changes in this molecule
expression at any time analyzed when compared with the
PBS group.
A similar effect was observed with VCAM-1 (Fig. 5). LPS
increased the VCAM-1 expression on HUVECs at 6 and 24 h
after treatment, while jararhagin did not induce any
expression as also observed for the PBS incubation.
As the protein E-selectin was not detected on the
HUVEC surface, we analyzed if it could be shed by the
action of jararhagin and then released as its soluble form in
the cell supernatant, by ELISA. No difference on the soluble
form of E-selectin was observed in the supernatants of
HUVECs treated with jararhagin (Fig. 6B).
The IL-8 secretion was also analyzed on the cell culture
supernatants. Our results demonstrate that jararhagin
treatment did not induce this cytokine secretion by
HUVECs, as showed in Fig. 6A, while the HUVECs incubated
with 1 ng/mL of LPS released signiﬁcant amounts of this
cytokine.
4. Discussion
The local tissue damage that occurs after Bothrops
envenomations is mainly characterized by local tissue
damage and bleeding that may evolve to necrosis which is
dependent on the expression of endogenous mediators
such as cytokines (Laing et al., 2003). Therefore, the char-
acterization of the major mediators and cells involved in
venom-induced acute inﬂammation contribute to a better
understanding of this pathogenesis and may help to
improve the treatment for the resolution of acute damage,
once the speciﬁc antivenom per se is not efﬁcient to treat
the local effects (Gutierrez et al., 1998). SVMPs are the most
abundant toxins present in the Brazilian Bothrops venoms
and represent signiﬁcant contributors to the local tissue
damage. To study the effect of SVMPs on human endothe-
lial cells initially we conducted a microarray analysis for
screening the genes that were up and down-regulated by
jararhagin over 24 h of treatment.
Previous studies of gene expression induced by jar-
arhagin are described in the literature (Gallagher et al.,
2003, 2005). Analyzing a human ﬁbroblast cell line (HS-
68) treated with jararhagin, Gallagher et al. (2005) showed716 up-regulated genes with fold changes greater than 1.5
and p values less than 0.05 and 406 genes down-regulated
with fold changes greater than 1.5 and p values less than
0.05 compared to un-treated cells. Comparing to our
results, we obtained a signiﬁcantly lower number of genes
in the jararhagin-treated HUVECs, 59 up-regulated with
fold changes greater than 1.5 and p values < 0.05 and 11
down-regulated with fold changes greater than 1.5 and p
values < 0.05 compared to un-treated cells. The difference
in total number of genes up or down-regulated observed
between ﬁbroblasts and endothelial cells can be attributed
due the difference in the origin of cells lines, once HS-68 is
an immortalized cell line and HUVECs are primary cell
culture, beside that different cell lines respond differently
to the same stimulus. Nevertheless when their data were
organized by functional ontologies, the same two cate-
gories associated with up-regulated genes, cell death and
inﬂammatory diseases were identiﬁed also in our experi-
ments with HUVECs.
Considering the endothelial cell culture, the number of
genes up- and down-regulated in HUVECs treated previ-
ously by B. jararaca venom (Gallagher et al., 2003) was
similar to the results presented here. The authors observed
a small number of genes up or down-regulated, being 33
genes up-regulated with 1.5 fold or greater and 11 genes
signiﬁcantly down-regulated (greater than1.5 fold) in the
B. jararaca venom-treated cells. However, the biological
processes represented by the whole venom or jararhagin
are different, with the majority of the venom-induced up-
regulated genes belonging to the ontology classes of cell
growth/maintenance and cell communications (biological
processes) and signal transduction (molecular function)
while in our results, the majority of up-regulated genes
corresponded to cell signaling and cell–cell interaction
genes, correlated to inﬂammatory disease.
The local inﬂammatory reaction that occurs after
Bothrops envenoming follows a typical hyper acute
inﬂammatory response characterized by over expression of
cytokines, chemokines, adhesion molecules and matrix
metalloproteinases, followed by inﬂammatory cell inﬁltrate
surrounding the local of snake bite (Barbosa-Souza et al.,
2011; Gutierrez et al., 2009; Lopes et al., 2009; Teixeira
et al., 2009). Between the main class of proteases present
in the Bothrops venoms (metalloproteinases and serine
proteinases), SVMPs have been demonstrated to play
a major contribution in the inﬂammatory reaction,
affecting directly the rolling, activation, adhesion and
extravasations of leukocytes into the injured tissue (Zychar
et al., 2010). Our microarray analysis conﬁrms the role of
inﬂammatory response produced by jararhagin on endo-
thelial cells, showing a great number of up-regulated genes
involved in inﬂammatory diseases (Table 1).
The time-course and quantitative increase in the
expression of some genes related to inﬂammatory reaction
previously detected by microarray was conﬁrmed in our
study by real-time PCR and then the protein expressionwas
evaluated on the cell surface or in the cell culture super-
natant by ﬂow cytometry or Enzyme-Linked Immu-
noabsorbent Assay. Genes coding for cytokines (IL-6, IL-8),
chemokines (CXCL-6) and adhesion molecules (E-selectin
and VCAM-1) were conﬁrmed to be signiﬁcantly up-
Fig. 3. Flow cytometric analysis of PECAM (CD31) cell-surface expression. HUVECs were treated with jararhagin (200 nM), LPS (1 ng/mL), or PBS (control group)
for 1, 3, 6 and 24 h and stained with anti-human CD31-Fluorescein or with isotype control. The results express the percentage of cells expressing PECAM-1. The
experiment was performed in triplicate and the signiﬁcance was calculated by Student’s T test. The symbol * represent signiﬁcant difference (p < 0.05) compared
to samples treated with the control.
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to those in un-stimulated cells.
The E-selectin gene expressed by jararhagin treatment
presented a fold change of 50 and 8 times higher
comparing to PBS, at 6 and 24 h after treatment, respec-
tively. Interestingly, only a low increase of this adhesion
moleculewas detected on cell surface at 1 h after jararhagin
treatment (11.83% for PBS and 17.06% for jararhagin). We
also observed that jararhagin up-regulated VCAM-1 gene
expression, after 6 h and 24 h of HUVECs treatment (4.5 and3 fold increase respectively) comparing to PBS; however,
VCAM-1 expressed on the HUVECs surface was not detec-
ted at any time. Supporting the results presented herein,
previous studies with berythractivase, a non-hemorrhagic
SVMP class P-III isolated from Bothrops erythromelas
venom, also up-regulated the expression of E-selectin on
the surface of HUVECs after 1 h of incubation, along with
the absence of detectable increases of VCAM-1 (Silva et al.,
2003). Although berythractivase and jararhagin belong to
SVMP class PIII, they present different effects on
Fig. 4. Flow cytometric analysis of E-selectin cell-surface expression. HUVECs were treated with jararhagin (200 nM), LPS (1 ng/mL), or PBS (control group) for 1,
3, 6 and 24 h and stained with anti-human E-selectin-Fluorescein or with isotype control. The results express the percentage of cells expressing E-selectin. The
experiment was performed in triplicate and the signiﬁcance was calculated by Student’s T test. The symbol * represent signiﬁcant difference (p < 0.05) compared
to samples treated with the control.
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thractivase did not change HUVECs morphology and did
not modulate cell survival, similar to the case of jararhagin
at low doses (Schattner et al., 2005).
The gene and protein expression of E-selectin and
VCAM-1 molecules induced by the control stimulus withLPS was detected in all our experiments. For E-selectin is
interesting to observe that gene and protein expression
occurred at the same time intervals, with 3, 6 and 24 h after
LPS treatment. However for VCAM-1 gene and protein
expression, we observed that the gene is activated at 3 h,
but no protein was detected at this time, indicating a delay
Fig. 5. Flow cytometric analysis of VCAM-1 cell-surface expression. HUVECs were treated with jararhagin (200 nM), LPS (1 ng/mL), or PBS (control group) for 1, 3,
6 and 24 h and stained with anti-human VCAM-1-Fluorescein or with isotype control. The experiment was performed in triplicate and the signiﬁcance was
calculated by Student’s T test. The symbol * represent signiﬁcant difference (p < 0.05) compared to samples treated with the control.
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tion, but at 6 and 24 h can be observed both gene and
protein increased expression.
PECAM-1 is constitutively expressed on endothelial
cells, where it is a major component of the endothelial cell
intercellular junction in conﬂuent vascular beds. During the
inﬂammatory response, PECAM is involved in a step inwhich leukocytes squeeze in amoeboid fashion between
the tightly apposed endothelial cells that line the blood
vessels at the site of inﬂammation (diapedesis) (Muller
et al., 1989; Newman, 1997). Our results of ﬂuorescent cell
sorting conﬁrm the expression of PECAM-1 in HUVECs at all
time intervals analyzed, independently of the treatment.
The decrease in the percentage of jararhagin treated cells
Figure 6. Detection of soluble IL-8 and E-selectin by jararhagin-treated
HUVECs. HUVECs were treated with jararhagin (200 nM) or LPS (1 ng/mL),
for 1, 3 and 6 h and the supernatant was assayed for soluble IL-8 or E-
selectin by ELISA (DuoSet-R&D Systems). The experiment was performed in
triplicate and the signiﬁcance was calculated by Student’s T test. The symbol
* represent signiﬁcant difference (p < 0.05) compared to samples treated
with the control.
D.S. Lopes et al. / Toxicon 60 (2012) 1072–10841082that expressed PECAM-1 molecule at 24 h may be
explained by the detachment or death of cells induced by
jararhagin at this time of treatment.
In this study, we showed also that jararhagin induces the
expression of extracellular matrix metalloproteinase MMP-
10 gene. Usually MMPs induce or suppress inﬂammatory
response through the regulation of cytokines (Manicone
and McGuire, 2008; Saren et al., 1996). MMPs are involved
in maintaining vascular homeostasis, by degrading most
extracellular matrix components, which are barriers to
normal migration and formation of new vessels (Visse and
Nagase, 2003). Published data demonstrate that SVMP
also regulated positively the expression of various pro-
inﬂammatory genes such as metalloproteinases (MMP-10,
MMP-1, MMP-3, tissue factor and urokinase type plasmin-
ogen activators) and expression of tissue inhibitors of
extracellular matrix metalloproteinases (TIMP-1 and TIMP-
3) in ﬁbroblasts, suggesting that SVMP could induce
a remodeling of extracellular matrix by activating these
components (Gallagher et al., 2003; Lopes et al., 2009).
Interestingly, the gene coding for angiopoietin-2 was
highly expressed by jararhagin-treated HUVEC. Pro-
inﬂammatory stimuli strongly activate transcription of
Ang-2 by endothelial cells (Kim et al., 2000; Mandriota and
Pepper, 1998). Ang-2 protein is stored in endothelial-cell
Weibel–Palade bodies (WPB) and, thus, is readily avail-
able following endothelial stimulation with WPBsecretagogues such as phorbol 12-myristate-13-acetate
(PMA), thrombin and histamine (Fiedler et al., 2004,
2006). The release of Ang-2 results in rapid destabilization
of the endothelium, suggesting that Ang-2 functions as an
autocrine negative regulator of the quiescent resting
endothelium (Pfaff et al., 2006; Scharpfenecker et al.,
2005). Moreover, Ang-2 triggers an inﬂammatory
response by activating the endothelium and inducing its
permeability (Lemieux et al., 2005; Roviezzo et al., 2005). In
our model, the increase in gene expression of Ang-2 indi-
cates that this molecule may contribute to inﬂammatory
action unleashed by jararhagin on endothelial cells, and has
not been studied.
Finally we observed increase of CD69 gene expression.
This molecule is expressed by various cells of hematopoi-
etic lineage, being related to activation and proliferation of
these cells. Some studies have shown the expression of
CD69 in HUVECs after inﬂammatory stimuli, as action of
thrombin (Okada et al., 2006) and TNF-a (Viemann et al.,
2006). However, future studies should be performed to
better characterize the expression and function of this
marker in endothelial cells after stimulation with
jararhagin.
Considering the inﬂammation as a multifactorial,
multicellular and complex event as it is (Petri et al., 2008)
and some considerations pointed here, it is important to
note that endothelial cells when removed from its natural
environment, are not inﬂuenced by other components
present in the vascular milieu (i.e. basement membrane,
extracellular matrix, ﬁbroblasts, myoblasts and leukocytes).
So the isolated endothelial cells, represented here by
HUVECs, seems to have little participation in the effective
release of cytokines, adhesion molecules and other pro-
inﬂammatory mediators induced directly by jararhagin,
although these cells present a complete gene transcription
system activated by this SVMP. On the other hand, it is well
known that the endothelial cells are of fundamental
importance for the inﬂammatory response induced any
agent. In particular by SVMPs, these toxins directly activate
(considering in vivo studies) the interaction between
leukocyte and endothelium and, thus, results in the local
inﬂammation observed during envenoming (Clissa et al.,
2006; Menezes et al., 2008).
It is important to cite also another fundamental role of
endothelial cells for a different event of local bothropic
envenoming, the hemorrhage. This occurs very rapidly
after venom injection, and nowadays this effect has been
mainly attributed to the indirect consequence of the SVMPs
action on their primary target, i.e. the basement membrane
(BM) of capillary vessels and related extracellular matrix
components that provide stability to micro vessel structure
(Baldo et al., 2010; Escalante et al., 2011; Serrano et al.,
2007). Also, it has been proposed that the rapid in vivo
damage of endothelial cells is the result of mechanical
hemodynamic forces operating in the microvasculature
which distend and disrupt the integrity of these cells after
an initial weakening of the stability of the BM occurring as
a consequence of proteolytic cleavage of BM components
(Gutiérrez et al., 2005, 2006).
In summary, our data indicated that most of the genes
up-regulated by treatment of HUVECs with jararhagin are
D.S. Lopes et al. / Toxicon 60 (2012) 1072–1084 1083related to the inﬂammatory response. Considering the
intrinsic function of some of these up-regulated genes (E-
selectin, VCAM-1, IL-8, MMP-10 and Ang-2) and the fact
that E-selectin, IL-8 and VCAM-1 protein production/
release was not detected, we suggest that the main role of
jararhagin on endothelium is to destabilize the quiescent
state and prime these cells to respond to exogenous stimuli
by facilitating the activities of inﬂammatory mediators.
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